Disease progression and survival in ALS: first multi-state model approach

Area of Science:

• Neurology
• Clinical Epidemiology

Background:

• Prognostic factors in Amyotrophic Lateral Sclerosis (ALS) require clarification, particularly the significance of age and clinical onset form.
• Existing models show discordance in predicting ALS progression and survival.

Purpose of the Study:

• To clarify the prognostic significance of age and clinical form at onset in sporadic ALS.
• To analyze prognostic factors using a multi-state model to differentiate their impact on disease progression and survival.

Main Methods:

• A cohort of 222 sporadic ALS patients was analyzed using a time-inhomogeneous Markov multi-state model.
• The model tracked disease progression through three states: neurological impairment (states 1 and 2) and end-of-follow-up (state 3: tracheotomy or death).
• Covariates including age at onset, clinical form, diagnostic delay, BMI, and SVC were assessed for their impact on transition intensities.

Main Results:

• The bulbar form at onset correlated with faster neurological impairment progression (state 1 to state 2).
• Advanced age at diagnosis specifically impacted survival from state 2 onwards.
• Other factors like gender, diagnostic delay, BMI, and SVC were also recorded but their specific transition impacts were detailed in the full analysis.

Conclusions:

• Age at onset is primarily related to patient survival in ALS.
• The clinical form at onset predicts the progression rate of motoneuronal impairment.
• The multi-state modeling approach effectively differentiates the prognostic roles of age and clinical onset form in ALS.